ConductScience.org, home

Paper7935686

Transforming growth factor beta in tissue fibrosis.

Border WA and 1 other. N Engl J Med, 1994. Cited by 2,872 papers, by iCite.

Cite this record

ConductScience Library. Transforming growth factor beta in tissue fibrosis. Papers, record 7935686. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7935686

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Transforming growth factor beta in tissue fibrosis.
PubMed
Journal
N Engl J Med
PubMed
Year
1994
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
2,872
iCite
Relative citation ratio, by iCite
82.2
iCite
Revised in PubMed
2022-04-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Border WAW A
2Noble NAN A

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FibrosisMajor topic
Transforming Growth Factor betaMajor topic
Animals
Cytokines
Humans
Kidney
Liver Cirrhosis
Pulmonary Fibrosis
Wound Healing

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
DK 43609NIDDK NIH HHSUnited StatesR01DK043609PubMed and NIHNIH RePORTER
R37DK043609NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00001959Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)Background

Source ClinicalTrials.gov

Download CSV of trials

Cited by836

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,872 citations.

PMIDTitleJournalYearIn PapersSource
42943198Beyond Weight Loss and Glycemic Control: Molecular Mechanisms and Hypothesis-Generating Therapeutic Potential of Incretin-Based Therapies Against Peritoneal Fibrosis in Peritoneal Dialysis.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943198PubMed
42830635Esaxerenone attenuates renal injury by inhibiting NR3C2-mediated inflammatory and fibrotic pathways.Ren Fail2026https://conductscience.org/library/papers/42830635PubMed
42738813Molecular Mechanisms of Intimal Hyperplasia in Saphenous Vein Grafts After Coronary Artery Bypass Grafting.Cells2026https://conductscience.org/library/papers/42738813PubMed
42712460Hypertension identified in early adulthood as an endocrine-vascular risk factor for uterine fibroids in reproductive-age women: a nationwide cohort study.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42712460PubMed
42702797Cord Blood-Derived Platelet Gel in Wound Healing: From Biological Rationale to Clinical Application.Wound Repair Regen2026https://conductscience.org/library/papers/42702797PubMed
42642530Plasminogen activator inhibitor-1 promotes the proliferation and blocks TGF-β1-dependent growth inhibition of cholesteatoma keratinocytes by ERK signaling.Eur Arch Otorhinolaryngol2026https://conductscience.org/library/papers/42642530PubMed
42566007Effects of laparoscopic splenectomy and azygoportal disconnection on liver reserve function for cirrhosis patients: a 1-year prospective study.Surg Endosc2026https://conductscience.org/library/papers/42566007PubMed
42518044Mathematical Modeling of Systemic Sclerosis and Its Treatment.Bull Math Biol2026https://conductscience.org/library/papers/42518044PubMed
42481476Vactosertib plus pembrolizumab in patients with non-microsatellite instability-high metastatic colorectal or gastric cancer: a multicenter, phase Ib/IIa study.Nat Commun2026https://conductscience.org/library/papers/42481476PubMed
42385711Targeted DNA triplex-forming oligonucleotide liposome for pulmonary fibrosis gene therapy.Cell Rep Med2026https://conductscience.org/library/papers/42385711PubMed
42298564PPARγ signalling pathway: molecular mechanisms and therapeutic potential in ligamentum flavum hypertrophy and lumbar spinal stenosis.J Transl Med2026https://conductscience.org/library/papers/42298564PubMed
42143387EDL6D, a bioactive peptide phenocopying SHBG-associated metabolic effects: a new preclinical lead compound for treating the metabolic dysfunction-associated fatty liver disease.J Transl Med2026https://conductscience.org/library/papers/42143387PubMed
42094953Beyond attenuation: a translational review of curative-intent pharmacological targets in idiopathic pulmonary fibrosis.Front Med (Lausanne)2026https://conductscience.org/library/papers/42094953PubMed
42042290Comparative Late Effects of Hemostatic Biomaterials on Wound Healing at 14 and 30 Days: An In Vivo Animal Study.J Funct Biomater2026https://conductscience.org/library/papers/42042290PubMed
41977373Cell-Targeted Inhibition of CaMK4 Suppresses Tertiary Lymphoid-like Structure Development in Lupus-Prone Mice.Int J Mol Sci2026https://conductscience.org/library/papers/41977373PubMed
41878126Inhalable TFRC-Targeted Extracellular Vesicles Delivery of siTGF-β1 Alleviates Pulmonary Fibrosis via Dual Inhibition of Ferroptosis and Fibroblast Activation.Int J Nanomedicine2026https://conductscience.org/library/papers/41878126PubMed
41682601Residual Renal Risk in Diabetic Nephropathy Despite Contemporary Therapies.J Clin Med2026https://conductscience.org/library/papers/41682601PubMed
41594645Efficacy of Modified Talc Powder in Experimental Rat Model of Pleurodesis.Biomolecules2026https://conductscience.org/library/papers/41594645PubMed
41567268Therapeutic Effects of Gallic Acid and Alpha-Tocopherol on Adenine-Induced Chronic Kidney Disease in Male Wistar Rats.Biochem Res Int2026https://conductscience.org/library/papers/41567268PubMed
41551214New frontiers in regenerative medicine: Protocol standardization and morphological assessment of leukocyte-platelet rich fibrin in cows, with a longitudinal study on growth factor release dynamics.Vet Anim Sci2026https://conductscience.org/library/papers/41551214PubMed

See all 836 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene
TGFBR27048PubTator's text mininghttps://conductscience.org/library/genes/7048NCBI Gene
TGFBR37049PubTator's text mininghttps://conductscience.org/library/genes/7049NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7935686

GET https://conductscience.org/api/papers/v1/7935686/cited_by?page=2